The Venture Codex

Participated · Equity · Jul 2026

Global Trust Networks offers comprehensive support for foreigners from pre-arrival through settlement and success, operating a multilingual support center (up to 25 languages, with hours varying by service) that handles housing, employment, communication and financial needs. The company supports not only individuals but also companies, municipalities and schools that recruit or accept foreign residents. A key feature is its rent guarantee business and associated risk-management capabilities—credit screening, examination and debt management—which GTN leverages to expand financial access for foreigners. GTN reports a cumulative user and supporter base exceeding 700,000 and handles over 200,000 lifestyle consultations annually. The company intends to develop a cross-functional platform using AI to provide individualized, timely support and is directing new capital toward strategic M&A and hiring product and development staff to accelerate that roadmap.

Participated · Series B · Jul 2026

JAPAN AI develops AI agent products aimed at enterprise customers to support corporate 'DX and AX' (digital transformation and AI transformation). The company focuses on expanding agent capabilities and integrating those agents with marketing SaaS to address automation needs driven by labor shortages. JAPAN AI is based in Tokyo and plans to use its Series B proceeds for hiring talent and product development. The firm secured institutional backing from major domestic investors, which the company and coverage framed as validation from potential corporate buyers. The company’s recent ¥1.9 billion Series B is its most recently disclosed funding event in the article.

Participated · Series B · Jul 2026

Neusignal Therapeutics is developing NTX-083, a novel low-molecule compound intended to treat Alzheimer’s disease via a mechanism distinct from existing therapies. The company completed a physician-initiated single-dose Phase 1 trial at the University of Tokyo Hospital (Feb–Sep 2025) and a company-sponsored multiple-dose Phase 1 trial (Nov 2025–Mar 2026) in healthy adults, with both Japanese trials reporting high safety, strong tolerability, and favorable pharmacokinetics and no significant side effects. Neusignal plans to begin a Phase 1b trial in Alzheimer’s patients in the United States later this year. The company intends to use the Series B proceeds to fund that U.S. trial and to expand its workforce ahead of potential strategic alliances with global pharmaceutical firms. Neusignal originated from Tohoku University and is headquartered in Tokyo.

Led · Series A · Jun 2026

GenerativeX is headquartered in Chiyoda-ku, Tokyo and is led by CEO Rei Araki. The company announced a Series A round raising approximately ¥650 million through a third-party allotment. The round was led by Nissay Capital with participation from Salesforce Ventures, Angel Bridge, Deepcore and SMBC Venture Capital. The company’s announcement did not disclose a valuation or prior funding history. The article did not provide details on the company’s products, operations, or financial metrics. The filing likewise did not specify intended use of the newly raised capital.

Led · Series B · Jun 2026

Founded in June 2019, MENOU offers "検査AI MENOU," a no-code visual inspection AI platform that enables on-site personnel to encode inspection know-how without programming. The company supplies end-to-end inspection solutions including imaging hardware, conveyance and ejection mechanisms, and integration with robotics, and reports deployments at more than 200 companies across industries such as auto parts, medical devices, food, and consumer goods. Investors and the company state that license counts and revenues have grown substantially year over year. MENOU plans continued software improvements based on customer feedback and aims to increase the system's generality and long-term usability. The company is using new funding to enhance product and service capabilities, expand office space in Tokyo and Osaka, strengthen its team, and open a showroom to bring MENOU closer to customers. Financially, the firm has accumulated about ¥890 million in equity financing and about ¥1.06 billion in total funding including loans.